Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 192

1.

The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.

Peuskens J, Pani L, Detraux J, De Hert M.

CNS Drugs. 2014 May;28(5):421-53. doi: 10.1007/s40263-014-0157-3. Review.

2.
3.

Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin).

Kelly DL, Wehring HJ, Earl AK, Sullivan KM, Dickerson FB, Feldman S, McMahon RP, Buchanan RW, Warfel D, Keller WR, Fischer BA, Shim JC.

BMC Psychiatry. 2013 Aug 22;13:214. doi: 10.1186/1471-244X-13-214.

4.

[Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].

Besnard I, Auclair V, Callery G, Gabriel-Bordenave C, Roberge C.

Encephale. 2014 Feb;40(1):86-94. doi: 10.1016/j.encep.2012.03.002. Epub 2013 Aug 5. Review. French.

PMID:
23928066
5.

Prolactin promotes cartilage survival and attenuates inflammation in inflammatory arthritis.

Adán N, Guzmán-Morales J, Ledesma-Colunga MG, Perales-Canales SI, Quintanar-Stéphano A, López-Barrera F, Méndez I, Moreno-Carranza B, Triebel J, Binart N, Martínez de la Escalera G, Thebault S, Clapp C.

J Clin Invest. 2013 Sep;123(9):3902-13. doi: 10.1172/JCI69485. Epub 2013 Aug 1.

6.

Evaluation of serum prolactin levels in intellectually disabled patients using antipsychotic medications.

Lambert TL, Farmer KC, Brahm NC.

Int J Endocrinol Metab. 2013 Winter;11(1):57-61. doi: 10.5812/ijem.4366. Epub 2012 Dec 21.

7.

The effect of the Taq1A variant in the dopamine D₂ receptor gene and common CYP2D6 alleles on prolactin levels in risperidone-treated boys.

Roke Y, van Harten PN, Franke B, Galesloot TE, Boot AM, Buitelaar JK.

Pharmacogenet Genomics. 2013 Sep;23(9):487-93. doi: 10.1097/FPC.0b013e3283647c33.

PMID:
23851570
8.

Prolactin serum levels in first-episode neuroleptic-naive patients with pituitary microadenoma and comorbid psychosis.

Cheng M, Wen S, Tang X, Zhong Z, Gan Z.

Psychiatry Res. 2013 Dec 15;210(2):590-3. doi: 10.1016/j.psychres.2013.06.027. Epub 2013 Jul 11.

PMID:
23850428
9.

Low-dose amisulpride and elevation in serum prolactin.

Andrade C.

J Clin Psychiatry. 2013 Jun;74(6):e558-60. doi: 10.4088/JCP.13f08510. No abstract available.

PMID:
23842026
10.

Effects of cabergoline on hyperprolactinemia, psychopathology, and sexual functioning in schizophrenic patients.

Kalkavoura CS, Michopoulos I, Arvanitakis P, Theodoropoulou P, Dimopoulou K, Tzebelikos E, Lykouras L.

Exp Clin Psychopharmacol. 2013 Aug;21(4):332-41. doi: 10.1037/a0033448. Epub 2013 Jul 8.

PMID:
23834553
11.

Hyperprolactinemia and estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data.

Tsuboi T, Bies RR, Suzuki T, Mamo DC, Pollock BG, Graff-Guerrero A, Mimura M, Uchida H.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug 1;45:178-82. doi: 10.1016/j.pnpbp.2013.05.010. Epub 2013 May 29.

12.

Drug-induced hypo- and hyperprolactinemia: mechanisms, clinical and therapeutic consequences.

Voicu V, Medvedovici A, Ranetti AE, Rădulescu FŞ.

Expert Opin Drug Metab Toxicol. 2013 Aug;9(8):955-68. doi: 10.1517/17425255.2013.791283. Epub 2013 Apr 21. Review.

PMID:
23600946
13.

Antipsychotic-induced sexual dysfunction and its management.

Park YW, Kim Y, Lee JH.

World J Mens Health. 2012 Dec;30(3):153-9. doi: 10.5534/wjmh.2012.30.3.153. Epub 2012 Dec 27.

14.

Striatal and extrastriatal dopamine D2 receptor occupancy by a novel antipsychotic, blonanserin: a PET study with [11C]raclopride and [11C]FLB 457 in schizophrenia.

Tateno A, Arakawa R, Okumura M, Fukuta H, Honjo K, Ishihara K, Nakamura H, Kumita S, Okubo Y.

J Clin Psychopharmacol. 2013 Apr;33(2):162-9. doi: 10.1097/JCP.0b013e3182825bce.

PMID:
23422369
15.

Dopamine D₂/₃ occupancy of ziprasidone across a day: a within-subject PET study.

Suzuki T, Graff-Guerrero A, Uchida H, Remington G, Caravaggio F, Borlido C, Pollock B, Mulsant B, Deluca V, Ismail Z, Mamo D.

Psychopharmacology (Berl). 2013 Jul;228(1):43-51. doi: 10.1007/s00213-013-3012-1. Epub 2013 Feb 17.

16.

Safety of cabergoline in the management of pituitary prolactin-induced symptoms with patients treated with atypical neuroleptics.

Coronas R, Cobo J, Giménez-Palop O, Ortega E, Márquez M.

Curr Drug Saf. 2012 Apr;7(2):92-8.

PMID:
22873493
17.

Effects of metoclopramide on mRNA levels of steroid 5α-reductase isozymes in prostate of adult rats.

Sánchez P, Torres JM, Castro B, Frías JF, Ortega E.

J Physiol Biochem. 2013 Mar;69(1):133-40. doi: 10.1007/s13105-012-0197-4. Epub 2012 Jul 18.

PMID:
22806172
18.

Not only dopamine D2 receptors involved in Peony-Glycyrrhiza Decoction, an herbal preparation against antipsychotic-associated hyperprolactinemia.

Wang D, Wong HK, Zhang L, McAlonan GM, Wang XM, Sze SC, Feng YB, Zhang ZJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3;39(2):332-8. doi: 10.1016/j.pnpbp.2012.07.005. Epub 2012 Jul 11.

PMID:
22796279
19.

[Hyperprolactinemia in mentally ill patients].

Carvalho MM, Góis C.

Acta Med Port. 2011 Nov-Dec;24(6):1005-12. Epub 2012 Feb 20. Review. Portuguese.

20.

Antipsychotic-induced hyperprolactinemia and testosterone levels in boys.

Roke Y, van Harten PN, Buitelaar JK, Tenback DE, de Rijke YB, Boot AM.

Horm Res Paediatr. 2012;77(4):235-40. doi: 10.1159/000337910. Epub 2012 Apr 26.

PMID:
22538969
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk